![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Abdel Moety GA, Almohamady M, Sherif NA, Raslana AN, Mohamed TF, El Moneam HM. 2016. Could first trimester assessment of placental functions predict preeclampsia and intrauterine growth restriction? A prospective cohort study. The Journal of Maternal-Fetal and Neonatal Medicine 29:413–417.
- Baschat AA. 2015. First-trimester screening for pre-eclampsia: moving from personalized risk prediction to prevention. Ultrasound in Obstetrics and Gynecology 45:119–129.
- Battaglia FC, Lubchenco LO. 1967. A practical classification of newborn infants by weight and gestational age. The Journal of Pediatrics 71:159–163.
- Chandra S, Scott H, Dodds L, Watts C, Blight C, Van den Hof M. 2003. Unexplained elevated maternal serum a-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes. American Journal of Obstetrics and Gynecology 189:75–78.
- Cole LA. 2009. New discoveries on the biology and detection of human chorionic gonadotropin. Reproductive Biology and Endocrinology 7:8.
- Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES. 2005. Birth weight standards in the live-born population in Israel. The Israel Medical Association Journal 7:311–314.
- Fitzgerald B, Levytska K, Kingdom J, Walker M, Baczyk D, Keating S. 2011. Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A. Placenta 32:339–345.
- Kirkegaard I, Henriksen TB, Uldbjerg N. 2011. Early fetal growth, PAPP-A and free β-hCG in relation to risk of delivering a small-for-gestational age infant . Ultrasound in Obstetrics and Gynecology 37:341–347.
- Kuc S, Wortelboer EJ, van Rijn BB, Franx A, Visser GHS, Schielen PCJI. 2011. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first trimester prediction of preeclampsia: a systematic review. Obstetrical and Gynecological Survey 66:225–239.
- Macri JN, Kasturi RV, Krantz DA, Cook EJ, Moore ND, Young JA. 1990. Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropin. American Journal of Obstetrics and Gynecology 163:1248–1253.
- Mikat B, Zeller A, Scherag A, Drommelschmidt K, Kimmig R, Schmidt M. 2012. βhCG and PAPP-A in first trimester: predictive factors for preeclampsia? Hypertension in Pregnancy 31:261–267.
- Odibo AO, Sehdev HM, Stamilio DM, Macones GA. 2006. Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction. American Journal of Perinatology 23:363–367.
- Odibo AO, Zhong Y, Longtine M, Tuuli M, Odibo L, Cahill LG. 2011. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction. Placenta 32:333–338.
- Onderoglu LS, Kabukcu A. 1997. Elevated second trimester human chorionic gonadotropin level associated with adverse pregnancy outcome. Reproductive Biology and Endocrinology 56:245–249.
- Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. 2000. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 107:1265e70.
- Shiefa S, Amargandhi M, Bhupendra J, Moulali S, Kristine T. 2013. First trimester maternal serum screening using biochemical markers PAPP-A and free b-hCG for Down syndrome, Patau syndrome and Edward syndrome. Indian Journal of Clinical Biochemistry 28:3–12.
- Sibai B, Dekker G, Kupferminc M. 2005. Pre-eclampsia. The Lancet 265:785–799.
- Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. 1999. A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound in Obstetrics and Gynecology 13:231–237.
- Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T. 1988. Maternal serum screening for Down’s syndrome in early pregnancy. BMJ (Clinical Research Ed.) 297:883–887.
- Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. 2003. First and second trimester antenatal screening for Down’s syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)). Journal of Medical Screening 10:56–104.
- Yaron Y, Ochshorn Y, Heifetz S, Lehavib O, Sapirc Y, Orr-Urtreger A. 2002. First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome. Fetal Diagnosis and Therapy 17:352–356.